Efficacy and Safety of FOLFIRINOX in Locally Advanced Pancreatic Cancer. A Single Center Experience.
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of FOLFIRINOX in Locally Advanced Pancreatic Cancer. A Single Center Experience.
Authors
Keywords
Pancreatic cancer, Locally advanced, FOLFIRINOX
Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume 23, Issue 4, Pages 753-759
Publisher
Springer Nature
Online
2017-01-07
DOI
10.1007/s12253-016-0176-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- More deaths from pancreatic cancer than breast cancer in the EU by 2017
- (2016) J. Ferlay et al. ACTA ONCOLOGICA
- Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer
- (2016) Steffi J. Rombouts et al. ANNALS OF SURGICAL ONCOLOGY
- Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer
- (2016) Stacey M Stein et al. BRITISH JOURNAL OF CANCER
- Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
- (2016) Andrea Wang-Gillam et al. LANCET
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
- (2016) Mustafa Suker et al. LANCET ONCOLOGY
- FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study
- (2016) SJ Rombouts et al. Journal of Cancer
- Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas
- (2014) Marlo Blazer et al. ANNALS OF SURGICAL ONCOLOGY
- FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort
- (2014) L. Marthey et al. ANNALS OF SURGICAL ONCOLOGY
- FOLFIRINOX for Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: The Royal Marsden Experience
- (2014) Sing Yu Moorcraft et al. Clinical Colorectal Cancer
- Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer
- (2013) Brian A. Boone et al. JOURNAL OF SURGICAL ONCOLOGY
- FOLFIRINOX in Locally Advanced Pancreatic Cancer: The Massachusetts General Hospital Cancer Center Experience
- (2013) J. E. Faris et al. ONCOLOGIST
- Modified FOLFIRINOX Regimen With Improved Safety and Maintained Efficacy in Pancreatic Adenocarcinoma
- (2013) Hemchandra Mahaseth et al. PANCREAS
- A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma
- (2012) Peter J Hosein et al. BMC CANCER
- FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity
- (2012) Krishna S. Gunturu et al. MEDICAL ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictive and Prognostic Value of CA 19-9 in Resected Pancreatic Adenocarcinoma
- (2009) Joshua G. Barton et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Analysis of mortality rates for pancreatic cancer across the world
- (2008) D. Hariharan et al. HPB
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation